The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMTPH.L Regulatory News (MTPH)

  • There is currently no data for MTPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

2 Nov 2016 12:57

RNS Number : 1560O
Midatech Pharma PLC
02 November 2016
 

 

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached:

 

Midatech Pharma Plc

2. Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

Yes

 

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached.

 

 

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

 

An event changing the breakdown of voting rights

Yes

 

Other (please specify):

 

Placing and open offer

3. Full name of person(s) subject to thenotification obligation:

 

Legal & General Group Plc (Group)

 

Legal & General Investment Management Limited (LGIM)

 

4. Full name of shareholder(s)  (if different from 3.):

Legal & General Assurance Society Limited (LGAS & LGPL)

 

5. Date of the transaction and date onwhich the threshold is crossed orreached:

 

31 October 2016

6. Date on which issuer notified:

02 November 2016

7. Threshold(s) that is/are crossed orreached:

 

LGIM (Above 5%), L&G (From 3% to 5%)

 

8. Notified details:

 

A: Voting rights attached to shares

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

 

Numberof shares

Number of votingrights

% of voting rights

Direct

Indirect

Direct

Indirect

ORD GBP 0.00005

 

1,043,500

(L&G)

 

 4,290,518

 2,472,018

 1,818,500

5.07%

3.73%

 First notification under DTR Sourcebook

(LGIM)

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

 

Type of financialinstrument

 

Expirationdate

 

Exercise/Conversion Period

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

 

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

 

Type of financialinstrument

 

 

Exercise price

 

Expiration date

 

Exercise/Conversion period

 

Number of voting rights instrument refers to

 

 

% of voting rights

 

 

 

Nominal

Delta

 

 

 

 

 

 

 

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

 

 2,472,018

(L&G)

 

5.07%

 4,290,518

(LGIM)

8.81%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable:

 

Legal & General Group Plc (Direct and Indirect) (Group) (4,290,518, 8.81% = Total Position)

Legal & General Investment Management (Holdings) Limited (LGIMH) (Direct and Indirect) (4,290,518, 8.81% = Total Position)

Legal & General Investment Management Limited (Indirect) (LGIM) (4,290,518, 8.81% = Total Position)

Legal & General (Unit Trust Managers) Limited (Below 5% = UTM)

Legal & General Group Plc (Direct) (L&G) (2,472,018, 5.07% = LGAS, LGPL & PMC)

Legal & General Investment Management (Holdings) Limited (Direct) (LGIMHD)

Legal & General Insurance Holdings Limited (Direct) (LGIH) (LGAS & LGPL)

Legal & General Assurance (Pensions Management) Limited (PMC)

Legal & General Assurance Society Limited (LGAS & LGPL) (LGAS & LGPL)

Legal & General Pensions Limited (Direct) (LGPL)

Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will ceaseto hold:

N/A

12. Date on which proxy holder will cease to holdvoting rights:

N/A

 

 

 

13. Additional information:

Notification using the total voting rights figure of  48,699,456

14. Contact name:

Victoria Davies (LGIM)

15. Contact telephone number:

029 2035 4147

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLBTBTTMBAMBFF
Date   Source Headline
14th Aug 20202:05 pmRNSSecond Price Monitoring Extn
14th Aug 20202:00 pmRNSPrice Monitoring Extension
14th Aug 20207:00 amRNSRegistration Statement Declared Effective
10th Aug 20205:36 pmRNSHolding(s) in Company
7th Aug 20207:00 amRNSHolding(s) in Company
6th Aug 20204:54 pmRNSHolding(s) in Company
6th Aug 20207:00 amRNSHolding(s) in Company
5th Aug 20207:00 amRNSHolding(s) in Company
5th Aug 20207:00 amRNSHolding(s) in Company
3rd Aug 20203:00 pmRNSHolding(s) in Company
31st Jul 20202:48 pmRNSResult of AGM
30th Jul 202011:00 amRNSPrice Monitoring Extension
30th Jul 20207:00 amRNSHolding(s) in Company
29th Jul 20204:35 pmRNSHolding(s) in Company
27th Jul 20209:40 amRNSBroker Option Fully Exercised
27th Jul 20207:00 amRNSUK Placing to Raise £5.0 million
24th Jul 20201:31 pmRNSHolding(s) in Company
24th Jul 20208:43 amRNSForm 8.3 - Midatech Pharma PLC
23rd Jul 20202:41 pmRNSForm 8.3 - Midatech Pharma plc
23rd Jul 20207:00 amRNSCorporate Update & Formal Sale Process Termination
22nd Jul 20203:25 pmRNSForm 8.3 - Midatech Pharma plc
21st Jul 20202:05 pmRNSSecond Price Monitoring Extn
21st Jul 20202:00 pmRNSPrice Monitoring Extension
21st Jul 202011:05 amRNSSecond Price Monitoring Extn
21st Jul 202011:00 amRNSPrice Monitoring Extension
21st Jul 20209:00 amRNSCollaboration for the Q-Sphera platform
3rd Jul 20205:48 pmRNSPosting of Annual Report & Notice of AGM
3rd Jul 20207:00 amBUSForm 8.3 - Midatech Pharma PLC
30th Jun 20201:37 pmRNSPublication of Annual Report
25th Jun 20203:10 pmRNSHolding(s) in Company
25th Jun 202012:01 pmRNSForm 8.3 - Midatech Pharma PLC
24th Jun 20205:18 pmBUSForm 8.3 - Midatech Pharma plc
24th Jun 202012:01 pmRNSForm 8.3 - Midatech Pharma PLC
18th Jun 20206:25 pmRNSForm 8 (DD) - Midatech Pharma plc
17th Jun 20207:00 amRNSGrant of Options
16th Jun 202010:20 amRNSInvestor Presentation
16th Jun 20207:00 amRNSResults for the year ended 31 December 2019
11th Jun 20203:41 pmRNSForm 8.3 - Midatech Pharma PLC
11th Jun 20203:35 pmRNSForm 8.3 - Midatech Pharma Plc
11th Jun 202010:53 amEQSForm 8.3 - Link Fund Solutions Ltd: Midatech Pharma Plc (Replacement)
11th Jun 20207:00 amRNSHolding(s) in Company
11th Jun 20207:00 amRNSHolding(s) in Company
10th Jun 20202:00 pmRNSPrice Monitoring Extension
10th Jun 202012:57 pmRNSForm 8.3 - Midatech Pharma plc
10th Jun 202011:00 amRNSPrice Monitoring Extension
9th Jun 20205:35 pmRNSForm 8.3 - Midatech Pharma plc
9th Jun 20204:36 pmRNSPrice Monitoring Extension
9th Jun 20204:04 pmRNSPurported Termination of MTX110 Licence Agreement
9th Jun 20202:48 pmEQSForm 8.3 - Link Fund Solutions Ltd: Midatech Pharma PLC
9th Jun 202012:14 pmRNSForm 8.3 - Midatech Pharma plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.